1613373-33-3
1613373-33-3
Chemical Structure
PCO371
- CAS No.: 1613373-33-3
- Formula:C29H32F3N5O6S
- Molecular Weight:635.65
IUPAC Name: 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethylimidazolidine-2,4-dione
InChIKey: LDZJFVOUPUFOHX-UHFFFAOYSA-N
SMILES: FC(F)(F)OC1=CC=C(C2=NC3(CCN(S(CCC4=C(C)C=C(N5C(NC(C5(C)C)=O)=O)C=C4C)(=O)=O)CC3)C(N2)=O)C=C1
Biological Activity: PCO371 is an orally active full agonist of parathyroid hormone receptor 1 (PTHR1), with no effect on PTH type 2 receptor.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PCO371 | 99.67% | PCO371 is an orally active full agonist of parathyroid hormone receptor 1 (PTHR1), with no effect on PTH type 2 receptor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
PCO371 (Standard) | ≥98% | PCO371 (Standard) is the analytical standard of PCO371 (HY-100856). This product is intended for research and analytical applications. PCO371 is an orally active full agonist of parathyroid hormone receptor 1 (PTHR1), with no effect on PTH type 2 receptor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
